Nasdaq
DMII
Drugs Made In America Acquisition II Corp.
- Finance
- Listed 2025
- 1 day
- +0.0%
- 1 month
- +0.1%
- 1 year
- —
$10.11
At the 6 Aug 2026 close
A blank-check shell — it has no operating business yet, only a mandate to find one.
Nasdaq
Drugs Made In America Acquisition II Corp.
$10.11
At the 6 Aug 2026 close
A blank-check shell — it has no operating business yet, only a mandate to find one.
Drugs Made In America Acquisition II Corp. trades under the ticker DMII on Nasdaq, in the Finance sector (Blank Checks). It has been listed since 2025. The last closing price was $10.11, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because DMII is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.